Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA-J Am Med Assoc. 2023;329:574–87.

Article  Google Scholar 

Tan AC, Ashley DM, Lopez GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA-Cancer J Clin. 2020;70:299–312.

Article  PubMed  Google Scholar 

McKinnon C, Nandhabalan M, Murray SA, Plaha P. Glioblastoma: clinical presentation, diagnosis, and management. BMJ-Brit Med J. 2021;374: n1560.

Article  Google Scholar 

Sharifzad F, Ghavami S, Verdi J, et al. Glioblastoma cancer stem cell biology: potential theranostic targets. Drug Resist Update. 2019;42:35–45.

Article  Google Scholar 

Goncalves D, Rodriguez RD, Kurth T, et al. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures. Acta Biomater. 2017;58:12–25.

Article  PubMed  CAS  Google Scholar 

Saliminejad K, Khorram KH, Soleymani FS, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234:5451–65.

Article  PubMed  CAS  Google Scholar 

Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immun. 2018;141:1202–7.

Article  PubMed  CAS  Google Scholar 

Zhu Q, Zhang Y, Li M, et al. MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling. Biomark Res. 2023;11:1.

Article  PubMed  PubMed Central  Google Scholar 

Song BF, Xu LZ, Jiang K, Cheng F. MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2. Funct Integr Genomic. 2023;23:80.

Article  CAS  Google Scholar 

Zo RB, Long Z. MiR-124-3p suppresses bladder cancer by targeting DNA methyltransferase 3B. J Cell Physiol. 2018;234:464–74.

Article  PubMed  Google Scholar 

Yan G, Li Y, Zhan L, et al. Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5. Am J Cancer Res. 2019;9:585–96.

PubMed  PubMed Central  CAS  Google Scholar 

Lin J, Wen X, Zhang X, et al. miR-135a-5p and miR-124-3p inhibit malignancy of glioblastoma by downregulation of syndecan binding protein. J Biomed Nanotechnol. 2018;14:1317–29.

Article  PubMed  CAS  Google Scholar 

Sendinc E, Shi Y. RNA m6A methylation across the transcriptome. Mol Cell. 2023;83:428–41.

Article  PubMed  CAS  Google Scholar 

Yang B, Wang JQ, Tan Y, Yuan R, Chen ZS, Zou C. RNA methylation and cancer treatment. Pharmacol Res. 2021;174: 105937.

Article  PubMed  CAS  Google Scholar 

Garbo S, Zwergel C, Battistelli C. m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options. Drug Discov Today. 2021;26:2559–74.

Article  PubMed  CAS  Google Scholar 

Alarcon CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF. N6-methyladenosine marks primary microRNAs for processing. Nature. 2015;519:482–5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng H, Yuan X, Wu S, et al. Effects of writers, erasers and readers within miRNA-related m6A modification in cancers. Cell Proliferat. 2023;56: e13340.

Article  CAS  Google Scholar 

Chen P, Hsu WH, Han J, Xia Y, DePinho RA. Cancer stemness meets immunity: from mechanism to therapy. Cell Rep. 2021;34: 108597.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Katoh M, Katoh M. WNT signaling and cancer stemness. Essays Biochem. 2022;66:319–31.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang Y, Zhang Z, Zhu Z, et al. The significance of EphA2-regulated Wnt/beta-catenin signal pathway in promoting the metastasis of HBV-related hepatocellular carcinoma. Mol Biol Rep. 2023;50:565–75.

Article  PubMed  CAS  Google Scholar 

Qin Y, Li L, Luo E, et al. Role of m6A RNA methylation in cardiovascular disease (Review). INT J Mol Med. 2020;46:1958–72.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Grossen A, Smith K, Coulibaly N, et al. Physical forces in glioblastoma migration: a systematic review. Int J Mol Sci. 2022;23:4055.

Article  PubMed  PubMed Central  CAS  Google Scholar 

So JS, Kim H, Han KS. Mechanisms of invasion in glioblastoma: extracellular matrix, Ca(2+) signaling, and glutamate. Front Cell Neurosci. 2021;15: 663092.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cesarini V, Silvestris DA, Tassinari V, et al. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion. Nucleic Acids Res. 2018;46:2045–59.

Article  PubMed  CAS  Google Scholar 

Yin CY, Kong W, Jiang J, Xu H, Zhao W. miR-7-5p inhibits cell migration and invasion in glioblastoma through targeting SATB1. Oncol Lett. 2019;17:1819–25.

PubMed  CAS  Google Scholar 

Hui X, Zhang S, Wang Y. miR-454-3p suppresses cell migration and invasion by targeting CPEB1 in human glioblastoma. Mol Med Rep. 2018;18:3965–72.

PubMed  CAS  Google Scholar 

Cai S, Shi CJ, Lu JX, Wang YP, Yuan T, Wang XP. miR-124-3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG. INT J Mol Med. 2021. https://doi.org/10.3892/ijmm.2021.4902.

Article  PubMed  PubMed Central  Google Scholar 

Zhang G, Chen L, Khan AA, et al. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis. Int J Cancer. 2018;143:635–44.

Article  PubMed  CAS  Google Scholar 

Sha J, Xia L, Han Q, et al. Downregulation of circ-TRPS1 suppressed prostatic cancer prognoses by regulating miR-124-3p/EZH2 axis-mediated stemness. Am J Cancer Res. 2020;10:4372–85.

PubMed  PubMed Central  CAS  Google Scholar 

Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–79.

Article  PubMed  CAS  Google Scholar 

Park JE, Son AI, Zhou R. Roles of EphA2 in development and disease. Genes-Basel. 2013;4:334–57.

Article  PubMed  PubMed Central  Google Scholar 

Hafner C, Schmitz G, Meyer S, et al. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem. 2004;50:490–9.

Article  PubMed  CAS  Google Scholar 

Wilson K, Shiuan E, Brantley-Sieders DM. Oncogenic functions and therapeutic targeting of EphA2 in cancer. Oncogene. 2021;40:2483–95.

Article  PubMed  PubMed Central  CAS